Name | Glumetinib |
---|
Description | Glumetinib (SCC244) is a potent and highly selective c-Met kinase inhibitor with an IC50 of 0.42 nM. Glumetinib shows antitumor activity and a superior safety margin[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.42 nM (c-Met kinase)[1] |
References |
Molecular Formula | C21H17N9O2S |
---|---|
Molecular Weight | 459.48 |